UBS maintains Colgate-Palmolive at 'buy' with a price target of $90.00

An analyst from UBS maintained Colgate-Palmolive (NYSE: CL ) at 'buy' with a price target of $90.00 from a prior price target of %currency%%price%.
Prior to this rating, Colgate-Palmolive had 9 buy ratings, 14 hold ratings, and 0 sell ratings.
For consensus analyst estimates and price targets on Colgate-Palmolive, click here. For more news on Colgate-Palmolive, click here.
Colgate-Palmolive's stock price closed at $75.91. They are up 1.35% in the last month and down -5.28% in the last 12 months.
According to Investing Pro, Colgate-Palmolive's fair value is $78.89, an upside of 3.92%. Colgate-Palmolive's fair value comes with a low degree of uncertainty, according to InvestingPro.
Check out Colgate-Palmolive's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb
Drop an image here or